AnkyrBio, LLC is a preclinical biotech drug delivery company that improves the efficacy of therapies in wet epithelial areas through its anchoring technology, called AnkyRx™.
Avista's mission is to develop innovative gene therapies for retinal diseases, including rare ophthalmic conditions that have a profound impact on quality of life.
NetraMind Innovations aims to revolutionize AMD screening and management globally while alleviating the strain on healthcare systems and improving patient outcomes.
Phosphoenix's mission is to restore functional and life-enhancing vision to those who have lost it using a visual prosthesis that bypasses the eyes and directly interfaces with the brain.
Science Corporation is developing a device that stimulates bipolar cells in the retina to restore vision in patients with macular degeneration.
Translating Pioneering Science into Vision-Saving Treatments.